VTYX (VTYX)
Ventyx Biosciences, Inc.
NASDAQ:VTYXHealthcare · Biotechnology
Mkt Cap-
Float-
O/S-
Inst Own-
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$0
Net Income-$135.12M
Total Assets$276.56M
Free Cash Flow-$131.11M
Debt & Equity
Debt 4%
Equity 96%
Total Debt$10.79M
Total Equity$254.04M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in VTYX's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$276.56M
Liabilities$22.52M
Accounts Receivable$1M
Accounts Payable$3.13M
Inventory$0
PP&E (Net)$10.28M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | - | - | - | - | - | - |
| Research and Development | $117M | $175.77M | $87.74M | $58.48M | $6.37M | $3.55M |
| Selling, General, and Administrative | $31.45M | $32.23M | $25.4M | $8.67M | $684K | $628K |
| Other | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $148.45M | $207.99M | $113.14M | $67.15M | $7.05M | $4.18M |
| Operating Income (EBIT) | -$148.45M | -$207.99M | -$113.14M | -$67.15M | -$7.05M | -$4.18M |
| Operating Margin | - | - | - | - | - | - |
| Interest Expense | $0 | $0 | $0 | $99K | $358K | $146K |
| Interest Income | $13.42M | $15.07M | $4.67M | $78K | $358 | $146 |
| Other Income (Expense) | $13.33M | $15.03M | $4.71M | -$16.6M | -$21.12M | -$147K |
| Income Before Tax (EBT) | -$135.12M | -$192.96M | -$108.43M | -$83.75M | -$28.17M | -$4.33M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$135.12M | -$192.96M | -$108.43M | -$83.75M | -$28.17M | -$4.47M |
| Net Income Margin | - | - | - | - | - | - |
| Supplementary Data | ||||||
| EPS | -1.97 | -3.30 | -2.06 | -1.69 | -0.56 | -2.29 |
| Diluted EPS | -1.97 | -3.30 | -2.06 | -1.69 | -0.56 | -2.29 |
| Weighted Average OS | 68.48M | 58.54M | 52.47M | 50.41M | 50.30M | 1.96M |
| EBITDA | -$133.77M | -$192.02M | -$107.96M | -$83.62M | $0 | -$1K |
| EBITDA Margin | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Assets | ||||||
| Current Assets | ||||||
| Cash and Cash Equivalents | $27.26M | $51.58M | $64.82M | $70.79M | $244K | $309K |
| Short-Term Investments | $190.06M | $200.64M | $253.12M | $187.78M | $0 | $0 |
| Cash and Short-Term Investments | $217.32M | $252.22M | $317.94M | $258.58M | $244K | $309K |
| Accounts Receivable | $1M | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $11.3M | $12.13M | $12.75M | $0 | $0 | $0 |
| Total Current Assets | $229.63M | $264.35M | $330.69M | $263.02M | $245K | $349K |
| Long-Term Assets | ||||||
| Property, Plant & Equipment Net | $10.28M | $12.27M | $1.94M | $254K | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $35.62M | $0 | $38.67M | $28.15M | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $1.03M | $1.08M | $96K | $60K | $0 | $0 |
| Total Long-Term Assets | $46.94M | $13.35M | $40.71M | $28.46M | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $276.56M | $277.69M | $371.4M | $291.48M | $245K | $349K |
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts Payable | $3.13M | $5.76M | $6.43M | $4.66M | $1.1M | $362K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Current Liabilities | $12.78M | $22.27M | $16.36M | $12.28M | $1.4M | $631K |
| Long-Term Liabilities | ||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $12.65M | $3.85M |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $16.85M | $0 |
| Total Long-Term Liabilities | $9.74M | $11.51M | $1.15M | $0 | $29K | $3.85M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $22.52M | $33.77M | $17.5M | $12.28M | $30.9M | $4.48M |
| Stockholders' Equity | ||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $7K | $6K | $6K | $5K | $0 | $0 |
| Retained Earnings | -$554.31M | -$419.19M | -$226.22M | -$117.8M | -$32.5M | -$4.33M |
| Comprehensive Income & Other | $157K | -$50K | -$1.12M | -$58K | $0 | $0 |
| Other Stockholders' Equity | $808.35M | $663.1M | $580.11M | $396.99M | $1.85M | $199K |
| Total Equity | $254.04M | $243.92M | $353.89M | $279.2M | -$30.65M | -$4.13M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $276.56M | $277.69M | $371.4M | $291.48M | $245K | $349K |
| Supplementary Data | ||||||
| Total Debt | $10.79M | $12.51M | $1.56M | $0 | $12.65M | $3.85M |
| Net Debt | -$16.47M | -$39.07M | -$63.26M | -$70.79M | $12.4M | $3.54M |
Cash Flow Statement
| Period | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Operating Activities | ||||||
| Net Income | -$135.12M | -$192.96M | -$108.43M | -$83.75M | -$28.17M | -$4.33M |
| Depreciation & Amortization | $1.35M | $941K | $470K | $30K | $7.05M | $4.18M |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $22.93M | $28.59M | $16.57M | $2.73M | $45K | $198K |
| Changes in Working Capital: | ||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | -$2.64M | -$745K | $1.61M | $2.44M | $591K | $361K |
| Other Working Capital | -$7.92M | $6.55M | -$6.77M | $1.57M | $221K | $230K |
| Total Working Capital Change | -$10.56M | $5.81M | -$5.16M | $4.02M | $812K | $591K |
| Other Non-Cash Items | -$9.47M | -$8.89M | -$2.23M | $38.32M | $14.07M | -$3.28M |
| Net Cash from Operating | -$130.87M | -$166.52M | -$98.77M | -$38.65M | -$6.2M | -$2.64M |
| Investing Activities | ||||||
| Capital Expenditures | -$241K | -$514K | -$275K | -$262K | $0 | $0 |
| Acquisitions | $0 | $0 | $75K | $1.9M | $0 | $0 |
| Purchases of Investments | -$283.65M | -$272.27M | -$347.24M | -$232.5M | $0 | $0 |
| Sales of Investments | $268.38M | $373.73M | $272.58M | $16.5M | $0 | $0 |
| Other Investing Activities | $0 | $0 | -$75K | $0 | $0 | $0 |
| Net Cash from Investing | -$15.51M | $100.94M | -$74.93M | -$214.37M | $0 | $0 |
| Financing Activities | ||||||
| Debt Repaid | - | - | - | -$450K | -$6.13M | -$2.95M |
| Common Stock Issuance | $95.05M | $48.41M | $165.4M | $158.81M | $2K | $1K |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $466K | $4.92M | $2.37M | $65K | $0 | $0 |
| Net Cash from Financing | $122.11M | $53.33M | $167.77M | $323.55M | $6.13M | $2.95M |
| Forex Effect | -$55K | -$12K | -$42K | $11K | $0 | $0 |
| Net Change in Cash | -$24.32M | -$12.27M | -$5.97M | $70.55M | -$65K | $309K |
| Supplementary Data | ||||||
| Operating Cash Flow | -$130.87M | -$166.52M | -$98.77M | -$38.65M | -$6.2M | -$2.64M |
| Capital Expenditure | -$241K | -$514K | -$275K | -$262K | $0 | $0 |
| Free Cash Flow | -$131.11M | -$167.04M | -$99.05M | -$38.91M | -$6.2M | -$2.64M |
| Cash at Beginning | $52.55M | $64.82M | $70.79M | $244K | $309K | $0 |
| Cash at End | $28.23M | $52.55M | $64.82M | $70.79M | $244K | $309K |